Biomarkers of dietary polyphenols in cancer studies: Current evidence and beyond

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Wang, Jincheng ^a   Tang, Lili ^a   Wang, Jia Sheng ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVONOIDS; FREQUENCY ESTIMATION; SURVEYS;

ADVERSE HEALTH EFFECTS; ANIMAL EXPERIMENTS; EPIDEMIOLOGICAL STUDIES; EPIGENETIC MODIFICATION; FRUITS AND VEGETABLES; GENETIC SUSCEPTIBILITY; GREEN TEA POLYPHENOLS; POSITIVE EVIDENCE;

DISEASES;

ANTHOCYANIN; BIOLOGICAL MARKER; CATECHIN; DAIDZEIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; EQUOL; ERIODICTYOL; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOL DERIVATIVE; GENISTEIN; HESPERETIN; ISOFLAVONE; ISOFLAVONE DERIVATIVE; NARINGENIN; POLYPHENOL; QUERCETIN; TUMOR MARKER;

ANTINEOPLASTIC ACTIVITY; BIOAVAILABILITY; BREAST CANCER; CANCER RISK; COLORECTAL CANCER; DIETARY INTAKE; DNA MODIFICATION; EPIGENETICS; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LUNG CANCER; MICROBIOME; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STOMACH CANCER; TEA; BREAST NEOPLASMS; DIETARY SUPPLEMENT; FEMALE; MALE; METABOLISM; NEOPLASMS; PATHOLOGY; PROSTATIC NEOPLASMS;

ANIMALIA;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; NEOPLASMS; POLYPHENOLS; PROSTATIC NEOPLASMS;

EID: 84935026930     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/732302     Document Type: Review

References (94)

1. A. Scalbert, C. Manach, C. Mor and , C. Rémésy, and L. Jiménez, "Dietary polyphenols and the prevention of diseases, " Critical Reviews in Food Science and Nutrition, vol. 45, no. 4, pp. 287-306, 2005
2. A. Scalbert, I. T. Johnson, and M. Saltmarsh, "Polyphenols: antioxidants and beyond, "The American Journal of Clinical Nutrition, vol. 81, no. 1, supplement, pp. 215S-217S, 2005
3. J. M. L and ete, "Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health, " Critical Reviews in Food Science and Nutrition, vol. 52, no. 10, pp. 936-948, 2012
4. I. C. W. Arts and P. C. H. Hollman, "Polyphenols and disease risk in epidemiologic studies, "The American Journal of Clinical Nutrition, vol. 81, no. 1, supplement, pp. 317S-325S, 2005
5. F. Visioli, C. A. de la Lastra, C. Andres-Lacueva et al., "Polyphenols and human health: a prospectus, " Critical Reviews in Food Science and Nutrition, vol. 51, no. 6, pp. 524-546, 2011
6. J.-S. Wang, H. Luo, P. Wang et al., "Validation of green tea polyphenol biomarkers in a phase II human intervention trial, " Food and Chemical Toxicology, vol. 46, no. 1, pp. 232-240, 2008
7. C.-L. Shen, M.-C. Chyu, and J.-S. Wang, "Tea and bone health: steps forward in translational nutrition, " The American Journal of Clinical Nutrition, vol. 98, no. 6, pp. 1694S-1699S, 2013
8. C. L. Shen, M. C. Chyu, J. K. Yeh et al., "Effect of green tea polyphenols and Tai Chi exercise on bone health in postmenopausal women with low bone mass: a 24-week placebocontrolled r and omized trial, " The FASEB Journal, vol. 25, p. 594.3, 2011
9. O. I. Parisi, F. Puoci, and D. Restuccia, "Polyphenols and their formulations: different strategies to overcome the drawbacks associated with their poor stability and bioavailability, " in Polyphenols in Human Health and Disease, R. R. Watson, V. R. Preedy, and S. Zibadi, Eds., chapter 4, pp. 29-45, Academic Press, San Diego, Calif, USA, 2014
10. A. Scalbert and G. Williamson, "Dietary intake and bioavailability of polyphenols, " Journal of Nutrition, vol. 130, no. 8, supplement, pp. 2073S-2085S, 2000
11. P. A. Kroon, M. N. Clifford, A. Crozier et al., "How should we assess the effects of exposure to dietary polyphenols in vitro?" The American Journal of Clinical Nutrition, vol. 80, no. 1, pp. 15-21, 2004
12. K. D. R. Setchell, N. M. Brown, L. Zimmer-Nechemias et al., "Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinalmetabolismfor bioavailability, "The American Journal of Clinical Nutrition, vol. 76, no. 2, pp. 447-453, 2002
13. C. S. Yang, L. Chen, M. J. Lee, D. Balentine, M. C. Kuo, and S. P. Schantz, "Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, " Cancer Epidemiology Biomarkers&Prevention, vol. 7, no.4, pp. 351-354, 1998
14. J. Linseisen and S. Rohrmann, "Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet-cancer relationship in humans, " European Journal of Nutrition, vol. 47, supplement 2, pp. 60-68, 2008
15. V. Kipnis, A. F. Subar, D. Midthune et al., "Structure of dietary measurement error: results of the OPEN Biomarker Study, " American Journal of Epidemiology, vol. 158, no. 1, pp. 14-21, 2003
16. C. Nagata, T. Mizoue, K. Tanaka et al., "Soy intake and breast cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population, " Japanese Journal of Clinical Oncology, vol. 44, no. 3, pp. 282-295, 2014
17. H. D. Woo and J. Kim, "Dietary flavonoid intake and risk of stomach and colorectal cancer, "World Journal of Gastroenterology, vol. 19, no. 7, pp. 1011-1019, 2013
18. H. D. Woo and J. Kim, "Dietary flavonoid intake and smokingrelated cancer risk: a meta-Analysis, " PLoS ONE, vol. 8, no. 9, Article ID e75604, 2013
19. S. Malerba, C. Galeone, C. Pelucchi et al., "A meta-Analysis of coffee and tea consumption and the risk of glioma in adults, " Cancer Causes and Control, vol. 24, no. 2, pp. 267-276, 2013
20. Z.-H. Hu, Y.-W. Lin, X. Xu et al., "No association between tea consumption and risk of renal cell carcinoma: a meta-Analysis of epidemiological studies, " Asian Pacific Journal of Cancer Prevention, vol. 14, no. 3, pp. 1691-1695, 2013
21. C. Hui, X. Qi, Z. Qianyong, P. Xiaoli, Z. Jundong, and M. Mantian, "Flavonoids, flavonoid subclasses and breast cancer risk: a meta-Analysis of epidemiologic studies, " PLoS ONE, vol. 8, no. 1, Article IDe54318, 2013
22. Z.-H. Wang, Q.-Y. Gao, and J.-Y. Fang, "Green tea and incidence of colorectal cancer: evidence from prospective cohort studies, " Nutrition and Cancer, vol. 64, no. 8, pp. 1143-1152, 2012
23. M. G. M. Braem, N. C. Onl and-Moret, L. J. Schouten et al., "Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-Analysis, " The American Journal of Clinical Nutrition, vol. 95, no. 5, pp. 1172-1181, 2012
24. N.-P. Tang, H. Li, Y.-L. Qiu, G.-M. Zhou, and J. Ma, "Tea consumption and risk of endometrial cancer: a metaanalysis, " American Journal of Obstetrics and Gynecology, vol. 201, no. 6, pp. 605.e1-605.e8, 2009
25. C. Manach, G. Williamson, C. Mor and , A. Scalbert, and C. Rémésy, "Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, " The American Journal of ClinicalNutrition, vol. 81, no. 1, supplement, pp. 230S-242S, 2005
26. J. Kühnau, "The flavonoids. A class of semi-essential food components: their role in human nutrition, " World Review of Nutrition and Dietetics, vol. 24, pp. 117-191, 1976
27. M.-L. Ovaskainen, R. Törrönen, J. M. Koponen et al., "Dietary intake and major food sources of polyphenols in Finnish adults, " Journal of Nutrition, vol. 138, no. 3, pp. 562-566, 2008
28. J. Pérez-Jiménez, L. Fezeu, M. Touvier et al., "Dietary intake of 337 polyphenols in French adults, " The American Journal of Clinical Nutrition, vol. 93, no. 6, pp. 1220-1228, 2011
29. R. Zamora-Ros, C. Andres-Lacueva, R. M. Lamuela-Raventos et al., "Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain), " Journal of the American Dietetic Association, vol. 110, no. 3, pp. 390-398, 2010
30. X. Wu, G. R. Beecher, J. M. Holden, D. B. Haytowitz, S. E. Gebhardt, and R. L. Prior, "Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption, " Journal of Agricultural and Food Chemistry, vol. 54, no. 11, pp. 4069-4075, 2006
31. G. Mazza and C. D. Kay, "Bioactivity, absorption, and metabolism of anthocyanins, " in Recent Advances in Polyphenol Research, pp. 228-262, Wiley-Blackwell, 2009
32. I. Fern and es, A. Faria, C. Calhau, V. de Freitas, and N. Mateus, "Bioavailability of anthocyanins and derivatives, " Journal of Functional Foods, vol. 7, no. 1, pp. 54-66, 2014
33. T. K. McGhie and M. C. Walton, "The bioavailability and absorption of anthocyanins: towards a better underst and ing, " Molecular Nutrition and Food Research, vol. 51, no. 6, pp. 702-713, 2007
34. R. M. de Ferrars, C. Czank, Q. Zhang et al., "The pharmacokinetics of anthocyanins and theirmetabolites in humans, " British Journal of Pharmacology, vol. 171, no. 13, pp. 3268-3282, 2014
35. D. Ingram, K. S and ers, M. Kolybaba, and D. Lopez, "Casecontrol study of phyto-oestrogens and breast cancer, " The Lancet, vol. 350, no. 9083, pp. 990-994, 1997
36. I. den Tonkelaar, L. Keinan-Boker, P. V. Veer et al., "Urinary phytoestrogens and postmenopausal breast cancer risk, " Cancer Epidemiology Biomarkers and Prevention, vol. 10, no. 3, pp. 223-228, 2001
37. R. Piller, J. Chang-Claude, and J. Linseisen, "Plasma enterolactone and genistein and the risk of premenopausal breast cancer, " European Journal of Cancer Prevention, vol. 15, no. 3, pp. 225-232, 2006
38. M. Verheus, C. H. van Gils, L. Keinan-Boker, P. B. Grace, S. A. Bingham, and P. H. M. Peeters, "Plasma phytoestrogens and subsequent breast cancer risk, " Journal of Clinical Oncology, vol. 25, no. 6, pp. 648-655, 2007
39. P. B. Grace, J. I. Taylor, Y.-L. Low et al., "Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk, " Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 5, pp. 698-708, 2004
40. W. Zheng, Q. Dai, L. J. Custer et al., "Urinary excretion of isoflavonoids and the risk of breast cancer, " Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 1, pp. 35-40, 1999
41. Q. Dai, A. A. Franke, F. Jin et al., "Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai, "Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 9, pp. 815-821, 2002
42. M. Iwasaki, M. Inoue, T. Otani et al., "Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan public health centerbased prospective study group, " Journal of Clinical Oncology, vol. 26, no. 10, pp. 1677-1683, 2008
43. N. Kurahashi, M. Iwasaki, M. Inoue, S. Sasazuki, and S. Tsugane, "Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center, " Journal of ClinicalOncology, vol. 26, no. 36, pp. 5923-5929, 2008
44. H. Ward, G. Chapelais, G. G. C. Kuhnle, R. Luben, K.-T. Khaw, and S. Bingham, "Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective intoCancer-Norfolk study, " Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 10, pp. 2891-2894, 2008
45. R. C. Travis, E. A. Spencer, N. E. Allen et al., "Plasma phytooestrogens and prostate cancer in the European Prospective Investigation into Cancer and Nutrition, " British Journal of Cancer, vol. 100, no. 11, pp. 1817-1823, 2009
46. S.-Y. Park, L. R. Wilkens, A. A. Franke et al., "Urinary phytoestrogen excretion and prostate cancer risk: a nested case-control study in theMultiethnic Cohort, " British Journal of Cancer, vol. 101, no. 1, pp. 185-191, 2009
47. M. D. Jackson, N. D. McFarlane-Anderson, G. A. Simon, F. I. Bennett, and S. P. Walker, "Urinary phytoestrogens and risk of prostate cancer in Jamaican men, " Cancer Causes and Control, vol. 21, no. 12, pp. 2249-2257, 2010
48. M. M. Nguyen, F. R. Ahmann, R. B. Nagle et al., "R and omized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities, " Cancer Prevention Research, vol. 5, no. 2, pp. 290-298, 2012
49. J.-M. Yuan, Y.-T. Gao, C. S. Yang, and M. C. Yu, "Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the ShanghaiCohort Study, " International Journal ofCancer, vol. 120, no. 6, pp. 1344-1350, 2007
50. C. L. Sun, J. M. Yuan, M. J. Lee et al., "Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China, " Carcinogenesis, vol. 23, no. 9, pp. 1497-1503, 2002
51. K.-P. Ko, S. K. Park, B. Park et al., "Isoflavones fromphytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort, " Cancer Epidemiology Biomarkers & Prevention, vol. 19, no. 5, pp. 1292-1300, 2010
52. A. Hara, S. Sasazuki, M. Inoue et al., "Plasma isoflavone concentrations are not associated with gastric cancer risk among japanese men and women, " Journal of Nutrition, vol. 143, no. 8, pp. 1293-1298, 2013
53. T. Shimazu, M. Inoue, S. Sasazuki et al., "Plasma isoflavones and the risk of lung cancer in women: a nested case-control study in Japan, " Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 3, pp. 419-427, 2011
54. H. Luo, L. Tang, M. Tang et al., "Phase IIa chemoprevention trial of green tea polyphenols in high-risk individuals of liver cancer: modulation of urinary excretion of green tea polyphenols and 8-hydroxydeoxyguanosine, " Carcinogenesis, vol. 27, no. 2, pp. 262-268, 2006
55. P. C. H. Hollman, J. H. M. de Vries, S. D. van Leeuwen, M. J. B. Mengelers, and M. B. Katan, "Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers, " The American Journal of Clinical Nutrition, vol. 62, no. 6, pp. 1276-1282, 1995
56. K. C. Ock, J. C. Sang, and W. O. Song, "Estimated dietary flavonoid intake and major food sources of U.S. adults, " Journal of Nutrition, vol. 137, no. 5, pp. 1244-1252, 2007
57. A. J. Day, F. Mellon, D. Barron, G. Sarrazin, M. R. A. Morgan, and G. Williamson, "Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin, " Free Radical Research, vol. 35, no. 6, pp. 941-952, 2001
58. E. U. Graefe, J. Wittig, S. Mueller et al., "Pharmacokinetics and bioavailability of quercetin glycosides in humans, " The Journal of Clinical Pharmacology, vol. 41, no. 5, pp. 492-499, 2001
59. J. H. Moon, R. Nakata, S. Oshima, T. Inakuma, and J. Terao, "Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 279, no. 2, pp. R461-R467, 2000
60. C. Manach, C. Mor and , A. Gil-Izquierdo, C. Bouteloup-Demange, and C. Rémésy, "Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two dose of orange juice, " European Journal of Clinical Nutrition, vol. 57, no. 2, pp. 235-242, 2003
61. J. T. Kumpulainen, "Intake of flavonoids, phenolic acids and lignans in various populations, " in Proceedings of the 3rd International Conference on Natural Antioxidants and Anticarcinogens in Food, Health and Disease, Kuopion University Publications D. Medical Sciences, Kuopio, Finl and , 2001
62. M. Kano, T. Takayanagi, K. Harada, S. Sawada, and F. Ishikawa, "Bioavailability of isoflavones after ingestion of soy beverages in healthy adults, " Journal of Nutrition, vol. 136, no. 9, pp. 2291-2296, 2006
63. K. Wakai, I. Egami, K. Kato et al., "Dietary intake and sources of isoflavones among Japanese, " Nutrition and Cancer, vol. 33, no. 2, pp. 139-145, 1999
64. Z. Chen, W. Zheng, L. J. Custer et al., "Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai, " Nutrition and Cancer, vol. 33, no. 1, pp. 82-87, 1999
65. T. Izumi, M. K. Piskula, S. Osawa et al., "Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans, " Journal of Nutrition, vol. 130, no. 7, pp. 1695-1699, 2000
66. K. D. R. Setchell, N. M. Brown, P. Desai et al., "Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements, " Journal of Nutrition, vol. 131, no. 4, supplement, pp. 1362S-1375S, 2001
67. K. D. R. Setchell, M. S. Faughnan, T. Avades et al., "Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women, " The American Journal of Clinical Nutrition, vol. 77, no. 2, pp. 411-419, 2003
68. D. L. McKay and J. B. Blumberg, "The role of tea in human health: an update, " Journal of theAmerican College of Nutrition, vol. 21, no. 1, pp. 1-13, 2002
69. D. A. Balentine, S. A. Wiseman, and L. C. M. Bouwens, "The chemistry of tea flavonoids, " Critical Reviews in Food Science and Nutrition, vol. 37, no. 8, pp. 693-704, 1997
70. O. J. Park and Y.-J. Surh, "Chemopreventive potential of epigallocatechin gallate and genistein: evidence fromepidemiological and laboratory studies, " Toxicology Letters, vol. 150, no. 1, pp. 43-56, 2004
71. M. J. Lee, Z. Y. Wang, H. Li et al., "Analysis of plasma and urinary tea polyphenols in human subjects, " Cancer Epidemiology Biomarkers and Prevention, vol. 4, no. 4, pp. 393-399, 1995
72. J. M. M. Van Amelsvoort, K. H. Van Het Hof, J. N. J. J. Mathot, T. P. J. Mulder, A. Wiersma, and L. B. M. Tijburg, "Plasma concentrations of individual tea catechins after a single oral dose in humans, " Xenobiotica, vol. 31, no. 12, pp. 891-901, 2001
73. M.-J. Lee, P. Maliakal, L. Chen et al., "Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability, " Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 10, pp. 1025-1032, 2002
74. H.-H. S. Chow, Y. Cai, D. S. Alberts et al., "Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E, " Cancer Epidemiology Biomarkers & Prevention, vol. 10, no. 1, pp. 53-58, 2001
75. J. Pérez-Jiménez, J. Hubert, L. Hooper et al., "Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review, "The American Journal of Clinical Nutrition, vol. 92, no. 4, pp. 801-809, 2010
76. T. J. Key, "Endogenous sex hormones and breast cancer in postmenopausalwomen: reanalysis of nine prospective studies, " Journal of the National Cancer Institute, vol. 94, no. 8, pp. 606-616, 2002
77. J. Ferlay, I. Soerjomataram, M. Ervik et al., GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer-Base No. 11, International Agency for Research on Cancer, Lyon, France, 2012, http://globocan.iarc.fr
78. T. Huang, J. Yu, L. Tang et al., "Phase IIa chemoprevention trial of green tea polyphenols in high-risk population of liver cancer: I. Design, clinical outcome, and baseline biomarker data, " International Journal of Cancer Prevention, vol. 1, no. 4, pp. 269-280, 2004
79. J.-S. Wang, T. Huang, and J. Yu, "Chemoprevention trial of green tea polyphenols in high-risk population of liver cancer, " Proceedings of American Association of Cancer Research, vol. 44, 2003
80. H. Luo, S. B. Cox, W.-M. Gao, J. Yu, L. Tang, and J.-S. Wang, "Metabolic profiling in validation of plasma biomarkers for green tea polyphenols, " Metabolomics, vol. 2, no. 4, pp. 235-241, 2006
81. H. Luo, L. Tang, M. Tang et al., "Validationof green teapolyphenol biomarkers in high-risk population of liver cancer, " in Proceedings of the 95th AnnualMeeting of American Association of Cancer Research, vol. 45, p. 931, Orl and o, Fla, USA, March 2004
82. A. Pilger, D. Germadnik, K. Riedel, I. Meger-Kossien, G. Scherer, and H. Rüdiger, "Longitudinal study of urinary 8-hydroxy-2-deoxyguanosine excretion in healthy adults, " Free Radical Research, vol. 35, no. 3, pp. 273-280, 2001
83. L. Tang, M. Tang, L. Xu et al., "Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention, " Carcinogenesis, vol. 29, no. 2, pp. 411-417, 2008
84. J. Yu, T. Huang, L. Zhang et al., "Chemoprevention trial of green tea polyphenols in high-risk population of liver cancer in southern Guangxi, China, " in Proceedings of the American Association of Cancer Research, vol. 2006, p. 1148, 2006
85. Y. L. Low, J. I. Taylor, P. B. Grace et al., "Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma and rogen concentrations in men, " Journal of Nutrition, vol. 135, no. 11, pp. 2680-2686, 2005
86. M. Inoue, K. Robien, R. Wang, D. J. Van Den Berg, W.-P. Koh, and M. C. Yu, "Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study, " Carcinogenesis, vol. 29, no. 10, pp. 1967-1972, 2008
87. M. Iwasaki, G. S. Hamada, I. N. Nishimoto et al., "Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians, " Cancer Science, vol. 100, no. 5, pp. 927-933, 2009
88. T. K. Lam, M. Rotunno, J. H. Lubin et al., "Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk, " Carcinogenesis, vol. 31, no. 4, pp. 634-642, 2010
89. I.-H. Lin, M.-L. Ho, H.-Y. Chen et al., "Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk, " PLoS ONE, vol. 7, no. 2, Article ID e30951, 2012
90. J. J. Yang, L. Y. Cho, K.-P. Ko et al., "Interaction effects between genes involved in the AKT signaling pathway and phytoestrogens in gastric carcinogenesis: a nested case-control study from the Korean Multi-Center Cancer Cohort, " Molecular Nutrition and Food Research, vol. 56, no. 11, pp. 1617-1626, 2012
91. J.-M. Yuan, W.-P. Koh, C.-L. Sun, H.-P. Lee, and M. C. Yu, "Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore, " Carcinogenesis, vol. 26, no. 8, pp. 1389-1394, 2005
92. A. Link, F. Balaguer, and A. Goel, "Cancer chemoprevention by dietary polyphenols: promising role for epigenetics, " Biochemical Pharmacology, vol. 80, no. 12, pp. 1771-1792, 2010
93. M. Fang, D. Chen, and C. S. Yang, "Dietary polyphenols may affect DNA methylation, " Journal of Nutrition, vol. 137, no. 1, supplement, pp. 223S-228S, 2007
94. D. del Rio, L. G. Costa, M. E. J. Lean, and A. Crozier, "Polyphenols and health: what compounds are involved?" Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 1, pp. 1-6, 2010